43
《药神》背后的中国药：红杉、高瓴老牌机构+产业背景机构加持 上半年药企并购受追捧
source link: https://www.pintu360.com/a56246.html?s=70&o=0
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.
在资本方面，直到几年前，才开始有本土投资机构触碰创新药领域。这种试探的碰，也从仿制药开始。
Recommend
About Joyk
Aggregate valuable and interesting links.
Joyk means Joy of geeK